Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritis

Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritis

Objectives The objective of this study is to investigate lipopolysaccharid-binding protein (LBP), zonulin and calprotectin as markers of bacterial translocation, disturbed gut barrier and intestinal inflammation in patients with radiographic axial spondyloarthritis (r-axSpA) during tumour necrosis f...

Full description

Saved in:

Bibliographic Details
Main Authors:	Denis Poddubnyy, Hildrun Haibel, Fabian Proft, Mikhail Protopopov, Valeria Rios Rodriguez, Murat Torgutalp, Judith Rademacher, Laura Spiller, Christine Maria Hempel
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-12-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/10/4/e004752.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapy
by: Joachim Sieper, et al.
Published: (2025-01-01)

Influence of sacroiliac joint variation on clinical features of axial spondyloarthritis: a comparative analysis
by: Denis Poddubnyy, et al.
Published: (2025-02-01)

The serum level of sclerostin decreases in radiographic axial spondyloarthritis patients with fatty lesions
by: Xuegang Li, et al.
Published: (2025-01-01)

Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study
by: Filip Van den Bosch, et al.
Published: (2025-02-01)

Occurrence and assessment of chronic pain fatigue and sleep disturbance in axial spondyloarthritis patients
by: Eman Abdel Ghani Sayed, et al.
Published: (2025-12-01)

Oxford textbook of axial spondyloarthritis
by: Vinod Ravindran
Published: (2017-01-01)

Osteoporosis in axial radiographic spondyloarthritis: diagnostic limitations of bone mineral density and the need for comprehensive fracture risk assessment
by: Paweł Żuchowski, et al.
Published: (2024-12-01)

Long-term safety and sustained efficacy of bimekizumab in patients with ankylosing spondylitis (radiographic axial spondyloarthritis): 5-year results from BE AGILE (phase 2b) and its open-label extension
by: Sofia Ramiro, et al.
Published: (2025-01-01)

Antiphospholipid Syndrome Associated with Nonradiographic Axial Spondyloarthritis
by: Jozélio Freire De Carvalho, et al.
Published: (2021-01-01)

Aberrant B cell receptor signaling responses in circulating double-negative 2 B cells from radiographic axial spondyloarthritis patients
by: Rick Wilbrink, et al.
Published: (2025-06-01)

Temporal Approach, Digitally Assisted Phacovitrectomy in a Patient with Severe Kyphosis due to Axial Spondyloarthritis
by: J. Rios-Nequis Geovanni, et al.
Published: (2021-01-01)

Sulfasalzine in the management of pure axial spondyloarthritis: Need to have a relook!
by: Subramanian Shankar, et al.
Published: (2020-01-01)

Treat-to-target strategy with secukinumab as a first-line biological disease modifying anti-rheumatic drug compared to standard-of-care treatment in patients with active axial spondyloarthritis: protocol for a randomised open-label phase III study, AScalate
by: Xenofon Baraliakos, et al.
Published: (2020-09-01)

Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab
by: A. Egeberg, et al.
Published: (2022-07-01)

South African Rheumatism and Arthritis Association 2024 guidelines for the management of axial spondyloarthritis
by: A B Maharaj, et al.
Published: (2024-10-01)

Efficacy of short term non steroidal anti-inflammatory drugs in Indian patients with axial spondyloarthritis
by: Shubha Bhalla, et al.
Published: (2018-01-01)

Axial Spondyloarthritis in Black Americans: An Observational Study From Five Centers in Shelby County, Tennessee
by: Krishna Kommineni, et al.
Published: (2025-01-01)

Distribution of spinal damage in patients with axial spondyloarthritis as assessed by MRI: a prospective and blinded study
by: Andreas Haidmayer, et al.
Published: (2025-01-01)

Axial spondyloarthritis in India: determining the delay in diagnosis, impact on work productivity, and attitude of patients toward treatment
by: Kamini Narendra Reddy, et al.
Published: (2020-01-01)

Colitis in spondyloarthritis
by: Muhammed Hafis, et al.
Published: (2020-01-01)

Spectrum of spondyloarthritis
by: Himanshu Pathak, et al.
Published: (2020-01-01)

Development of an Auxiliary Device for Patellar and Femoral Joint Tangential Axial Radiographic Imaging and a Method for Obtaining an Optimal Radiographic Image Using the Development
by: Do-Byung Rhee, et al.
Published: (2022-01-01)

Comparing the Accuracy and Reliability of Detecting the Intensity of Spinal Inflammation on STIR Sequence with Apparent Diffusion Coefficient Values in Axial Spondyloarthritis
by: Ho Yin Chung, et al.
Published: (2024-12-01)

Serum levels of tumor necrosis factor-alpha and vascular endothelial growth factor as markers of disease activity in patients with axial spondyloarthritis
by: Mahendran Bhuvanesh, et al.
Published: (2018-01-01)

Current concepts in the pathogenesis of spondyloarthritis
by: Nibha Jain, et al.
Published: (2020-01-01)

Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events
by: Mark Lebwohl, et al.
Published: (2025-01-01)

Antisynthetase syndrome with anti-glycyl tRNA synthetase antibodies in a patient with axial spondyloarthritis treated with tumor necrosis factor-α inhibitors
by: Maria Iacovantuono, et al.
Published: (2025-02-01)

Enteropathic Spondyloarthritis: From Diagnosis to Treatment
by: Rosario Peluso, et al.
Published: (2013-01-01)

Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial
by: Xiaomei Li, et al.
Published: (2025-01-01)

Myeloid-related proteins 8/14 failed to act as theragnostic biomarker in axial spondyloarthritis patients on combination disease-modifying anti-rheumatic drugs therapy
by: Arvind Ganapati, et al.
Published: (2020-01-01)

Correction: Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial
Published: (2025-01-01)

Diagnosis of spondyloarthritis: Application of criteria in clinical practice
by: Sham Santhanam, et al.
Published: (2020-01-01)

Clinical Characteristics and Treatment Options of Peripheral Spondyloarthritis
by: ZENG Lulu, et al.
Published: (2024-12-01)

Variation in the Permeability of Intact and Fractured Rocks due to Transient Disturbances in Axial Stress or Pore Pressure
by: Sophea Boeut, et al.
Published: (2019-01-01)

Construct validity and responsiveness of ASAS Health Index assessed in two longitudinal studies of tumour necrosis factor alpha inhibitor initiation and dose reduction in patients with axial spondyloarthritis
by: Merete Lund Hetland, et al.
Published: (2024-12-01)

IL-7 is a Key Driver Cytokine in Spondyloarthritis?
by: Rafaela Silva Guimarães Gonçalves, et al.
Published: (2019-01-01)

Biomechanics in the onset and severity of spondyloarthritis: a force to be reckoned with
by: Mark Hwang, et al.
Published: (2023-11-01)

Spondyloarthritis associated with inflammatory myositis: An unusual case report
by: Pradip Kumar Prajapati
Published: (2019-01-01)

The Influence of Vitamin D Receptor Gene Polymorphisms in Spondyloarthritis
by: Janisleya Silva Ferreira Neves, et al.
Published: (2020-01-01)

Acute Q Fever in an Ankylosing Spondyloarthritis Patient Treated with Etanercept
by: A. Guiga, et al.
Published: (2021-01-01)